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Abstract
Airway nitric oxide (NO) is a ubiquitous signaling molecule with bronchoprotective, antiinflammatory and anti-infective roles. Cystic fibrosis (CF) is a chronic lung condition associated
with deceased exhaled NO. Strategies to increase exhaled NO in CF have yielded inconsistent
results. A potential new method of increasing systemic NO involves ingestion of dietary,
inorganic nitrate which is reduced to nitrite and NO. We present the case of a 12 year-old,
athletic male with CF who demonstrated acute but marked increases in exhaled NO following
dietary nitrate consumption compared to placebo.
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Introduction
Nitric oxide (NO) is a ubiquitous signaling molecule with multiple systemic and airway roles.
Cystic fibrosis (CF) is a chronic lung condition which is associated with decreased fraction of
exhaled NO (FeNO)1-4.

The impact of decreased FeNO in CF is unclear. However, potentially of relevance to CF, NO
has bronchoprotective, anti-inflammatory and anti-infective roles as well as effects on ion
transport5 and ciliary motility6. Interestingly, pulmonary function in CF subjects is positively
correlated to airway NO7 and sputum NO metabolites8. Further, NO deficiency contributes to
impairment of airway relaxation in a murine model of CF1. Therefore, increasing NO levels may
be of functional importance in CF. Strategies to increase FeNO in CF have included inhaled NO,
L-arginine and PDE5 inhibitors (e.g. sildenafil ®) but have yielded inconsistent safety and
efficacy profiles (table 3).

Until recently, it was thought that the only pathway for NO synthesis in vivo was via oxidation of
L-arginine in the presence of oxygen catalysed by NO synthase (NOS) enzymes. However
recently an alternative pathway for in vivo NO synthesis has been discovered whereby inorganic
nitrate is reduced by oral bacteria to nitrite. This nitrite can be further reduced to NO
enzymatically and non-enzymatically9. Dietary nitrate is now recognized as an additional and
very significant source of NO, whereby a single serving of a nitrate rich vegetables (e.g. spinach)
contains more nitrate than what is endogenously formed by the all three NOS isoforms combined
in 24h9. Recent human intervention trials have demonstrated hypotensive and ergonomic effects
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of dietary nitrate in conjunction with increased blood NO metabolites among multiple healthy
and clinical groups.

Case report
We present a 12 year-old, non-smoking, athletic, male (BMI = 19 kg/m2) with CF, normal lung
function (FEV1 = 105%) and pancreatic sufficiency. This case initially presented early in life
with a history of recurrent chest infections and wheezy episodes. An initial sweat test chloride of
112 and confirmatory sweat test chloride of 106 in addition to genotype analysis
(F508/c.262_263delTT) lead to a CF diagnosis at 9 months of age. Current investigations
revealed a normal x-ray, DEXA, and glucose tolerance test with no recent hospital admissions or
gastrointestinal symptoms. Further, the case had no other medical history of note, including no
asthma or allergy (which could influence FeNO measurement). He generally requires antibiotics
every 8-12 weeks but had no recent infection or antibiotic use and had no evidence of concurrent
bacterial colonization. Further his medication regimen was stable and typical for a CF case (table
1). We utilized a double-blind, randomized, placebo-controlled, crossover design to assess the
acute impact of dietary nitrate as 140ml beetroot juice (BRJ, 12.9mmol nitrate) or 140ml
matched, nitrate-depleted beetroot juice (PL, <0.5mmol) on exhaled NO. This nitrate dose is
obtainable with a diet rich in vegetables.

We conducted two clinic visits 14 days apart, where there were no relevant changes in factors
known to influence NO (including diet, exercise and medication habits). On the morning of each
study visit, the subject did not use any medications or complete chest physio and consumed an
identical, low nitrate breakfast which was confirmed by a review with a dietitian (CPK). On both
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days, in an identical manner and at the same time, FeNO (NiOx MINO; Aerocrine, Sweden) and
pulmonary function were assessed before and 1.5h after the study beverage. We added water and
blackcurrant cordial (sugar- and nitrate-free) to the juice in an identical manner on both days to
make it more palatable at the request of the subject. The 1.5h delay between baseline and postbeverage testing was to facilitate in-vivo reduction of dietary nitrate to NO9. During this delay,
the case rested quietly in a clinic room and did not exercise, eat, drink or take medication. This
case report intervention complies with the Declaration of Helsinki and approval was granted by
the research ethics committee of The National Children’s Hospital. Written informed consent
was provided by the mother for permission to conduct and publish this case report.

There was no effect on pulmonary function after either beverage. However, 1.5h following BRJ,
FeNO increased by 150% (30ppb) but decreased by 17% after PL (-4ppb) (figure 1 and table 2).

Discussion
To our knowledge, this is the first report of dietary nitrate in CF. The acute but marked FeNO
incease following dietary nitrate compares favourably to other NO therapies in CF (table 3).
Interestingly, the subject studied here did not have low baseline FeNO (20ppb). Dietary nitrate as
a precursor to NO seems most effective in those with dysregulated NO and therefore it is
possible that dietary nitrate may increase FeNO to a similar or greater extent in those with
diminished baseline FeNO. Despite an increase in FeNO, there was no effect on lung functon. In
this context, it is noteworthy that baseline lung function was not impaired (105%), perhaps
minimising any potential benefit.
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Dietary nitrate is water soluble and rapidly absorbed ~100% in the stomach and small intestine.
There is no evidence of nitrate malabsorption in CF. Approximately 75% of ingested nitrate is
excreted via the kidneys with the remainder concentrated in the oral gland and subsequently
reduced to nitrite by tongue anaerobes. This nitrite is swallowed and then further reduced to NO
under suitable conditions within the airway, stomach and endothelium. After nitrate ingestion,
salivary/plasma nitrate levels increase rapidly (~15m) and peaking at 90-120m13. The levels
remain high for several hours following ingestion after which they slowly decline, remaining
elevated from baseline for ~24h13. This is why we measured FeNO before and 1.5h after each of
2 beverages. Further, we measured total exhaled NO. Future studies may utilize different doses
of nitrate among larger groups as well employ serial measurements of NO, nitrate and nitrite to
further our understanding of NO metabolism in response to exogenous nitrate in CF.
Importantly, this CF case did not display several behaviors known to decrease the reduction of
dietary nitrate to NO including use of tobacco14 antibiotics15 or mouthwash16.

Although, our report is limited to a single male, CF case with mild disease, dietary nitrate is a
component of certain vegetables, appears remarkably safe and increased FeNO to a greater
extent than exisitng CF therapies.

Nitrate and nitrate, as precursors to NO, are known to have broad antimicrobial effects10-12,
including against common pathogens in CF such as Pseudomonas aeruginosa10, 12 and
Staphylococcus aureus12. Further, this antimicrobial activity has been demonstrated under cystic
fibrosis airway conditions10.
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We recommend that future studies measuring FeNO are aware of potential confounding by
dietary intake. Further the dietetic focus regarding CF typically emphasizes dietary fat with little
focus on vegetable intake. We suggest the dietary modification of FeNO, including via vegetable
consumption in CF is worthy of further exploration. We suggest the dietary modification of
FeNO, including via vegetable consumption in CF is worthy of further exploration.
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Table 1: Current medication regimen
Bronchodilators

Ventolin
Flixotide

PERT

Creon

Airway clearence aid

Nebulized pulmozyme

Nutritional supplements

Vitamin D
Aquadex
Probiotics

Chest physio

Twice daily with acapella® device.

PERT = pancreatic enzyme repalcement therapy.
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Table 2: Pulmonary function tests
Day 1

Day 2

BRJ

PL

FeNO (ppb)

20

24

FVC L (%)

3.66 (106)

3.63 (105)

FEV1 L (%)

3.07 (107)

3.03 (105)

FeNO (ppb)

50

20

FVC L (%)

3.67 (106)

3.52 (101)

FEV1 L (%)

3.06 (106)

2.9 (101)

Intervention
Baseline

Post beverage

Abbreviations:
BRJ = nitrate-rich neetroot juice; FeNO = fraction exhaled nitric oxide; FEV1 = forced expiratory volume; FVC =
forced vital capacity; ppb = parts per billion; PL = placebo - nitrate-depleted beetroot juice.
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Oral Larginine at a
dose of 150
mg/kg/day
Oral Larginine at a a
dose of 200
mg/kg

Oral Larginine (600
mg/kg/day)
followed by
placebo or
vice versa

Ivacaftor

Dietary nitrate
(12.9mmol)
vs. placebo
(0.5mmol)

6 children with
(3 male, aged
6-16y)

11 subjects (6
male, aged 1541y) after 2
weeks of
antibiotic
therapy

15 CF cases

A single case
(male, aged
12)

Acute

4 weeks

6 weeks

Acute

Intervention
period
4 weeks

20ppb

8.5±5.0

11.4±6ppb

5.4±2.1ppb

Baseline
FeNO
Not reported

50ppb

16.2±15.5ppb

9.7ppb

Increased to
6.5ppb at 1h
(p=0.06) and
9.2ppb at 3h
(p=0.02)

Not reported

End FeNO

Increased
by 7.7ppb
(+90%)
Increased
by 30ppb
(+150%)

Decreased
by 1.7ppb (18%)

Effect on
FeNO
No
significant
impact on
FeNO
Increased
by 1.1ppb
(+20%) at
1h and by
3.8ppb
(+70%) at
3h
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FeNO decreased
after PL (-4ppb,
17%)

Significant
increases in
plasma arginine
and products of
L-arginine
metabolism by
arginase
(ornithine and
urea) but not
citrulline (the
product of Larginine
conversion by
NOS)
FeNO decreased
after 6w placebo
by 6.3ppb which
was significantly
lower than FeNO
at baseline
(p=0.001) and
after L-arginine
(p=0.003)
-

Plasma Larginine
increased
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Abbreviations: FeNO = fraction of exhaled nitric oxide; PL = placebo; ppb = parts per billion.

8 subjects (3
male, aged
range 14–37y)

Intervention

Sample

Comment

doi:10.3121/cmr.2016.1320

Table 3: Comparison of FeNO response to oral nitrate and L-arginine in CF
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Current case
report

Grasemann et al
20154

Grasemann et al
20053

Grasemann et al
20053

Everard &
Donnelly 20052

References

Kerley et al.

doi:10.3121/cmr.2016.1320

Figure 1: FeNO response to BRJ and PL
55

45

FeNO (ppb)

35

25

15

5

-5

Baseline

1.5h after BRJ

Baseline

1.5h after PL

Abbeviations:

BRJ = nitrate-rich; PL = placebo, nitrate-depleted beetroot juice.
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